Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2023-08-29 to 2023-09-20
Current total value of award: $10038.9
Description: 4562020307!ZOLADEX 3.6 MG IMPLANT SYRNS